XML 51 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair value measurements
6 Months Ended
Sep. 30, 2012
Fair value measurements [Abstract]  
Fair value measurements
4.   Fair value measurements:

The following table presents the level within the fair value hierarchy at which the Company's financial assets are carried at fair value and measured on a recurring basis:

(In thousands)
Description
 
Fair value at
September 30, 2012
 
 
Quoted prices in active markets for identical assets
 (Level 1)
 
 
Significant other observable
market inputs
 (Level 2)
 
 
Unobservable
market inputs
 (Level 3)
 
Money market accounts
 
$
913,623
 
 
$
891,618
 
 
$
22,005
 
 
 
 
Municipal bonds and notes
 
 
68,063
 
 
 
 
 
 
 
68,063
 
 
 
 
Commercial paper
 
 
314,292
 
 
 
81,084
 
 
 
233,208
 
 
 
 
Variable rate demand notes
 
 
4,000
 
 
 
 
 
 
 
4,000
 
 
 
 
Floating rate notes
 
 
241,976
 
 
 
241,976
 
 
 
 
 
 
 
 
Auction rate securities
 
 
14,773
 
 
 
 
 
 
 
 
 
 
$
14,773
 
Certificates of deposit
 
 
192,232
 
 
 
53,019
 
 
 
139,213
 
 
 
 
 
Corporate bonds
 
 
994,622
 
 
 
 
 
 
 
994,622
 
 
 
 
 
Government agency bonds
 
 
153,198
 
 
 
 
 
 
 
153,198
 
 
 
 
 


Description
 
Fair value at
March 31, 2012
 
 
Quoted prices in active markets for identical assets
 (Level 1)
 
 
Significant other observable
market inputs
 (Level 2)
 
 
Unobservable
market inputs
 (Level 3)
 
Money market accounts
 
$
1,059,868
 
 
$
938,526
 
 
$
121,342
 
 
 
 
Municipal bonds and notes
 
 
69,613
 
 
 
 
 
 
 
69,613
 
 
 
 
Commercial paper
 
 
556,794
 
 
 
284,981
 
 
 
271,813
 
 
 
 
Variable rate demand notes
 
 
4,000
 
 
 
 
 
 
 
4,000
 
 
 
 
Floating rate notes
 
 
467,259
 
 
 
467,259
 
 
 
 
 
 
 
 
Auction rate securities
 
 
25,089
 
 
 
 
 
 
 
 
 
 
$
25,089
 
Certificates of deposit
 
 
215,801
 
 
 
87,904
 
 
 
127,897
 
 
 
 
 
Corporate bonds
 
 
568,775
 
 
 
 
 
 
 
568,775
 
 
 
 
 
Government agency bonds
 
 
152,916
 
 
 
 
 
 
 
152,916
 
 
 
 
 

The Company determined fair value based on a market approach using quoted market values, significant other observable inputs for identical or comparable assets or liabilities, or discounted cash flow analyses. As of September 30, 2012, the Company determined the value of the auction rate securities portfolio based upon a discounted cash flow model.  The assumptions used in the valuation model include estimates for interest rates, timing and amount of cash flows, and expected holding periods for the auction rate securities.

The following table presents a reconciliation of the Level 3 investments measured at fair value on a recurring basis using unobservable inputs:

(In thousands)
 
Six Months Ended
September 30,2012
 
 
 
 
Balance at beginning of period
 
$
25,089
 
Sales
 
 
( 9,564
)
Unrealized (loss)
 
 
( 752
)
Balance at end of period
 
$
14,773
 

There were no purchases of Level 3 investments during the six-month period ended September 30, 2012. The Company recorded sales of $9.6 million of its Level 3 auction rate securities for the six-month period ended September 30, 2012.  In conjunction with these sales, the Company recognized a gain of $0.2 million.

In addition to the above, the Company also has Level 3 fair value measurements related to the Clinical Data, Inc. (Clinical Data) acquisition; see Note 12 for further information.

The majority of the Company's non-financial assets and liabilities are not required to be carried at fair value on a recurring basis.  However, the Company is required on a non-recurring basis to use fair value measurements when analyzing asset impairment as it relates to goodwill, license agreements, product rights and other intangible assets and long-lived assets.  The carrying amount of cash, accounts receivable and accounts payable and other short-term financial instruments approximate their fair value due to their short-term nature.